Solarea Bio
Solaria Bio
Cambridge, United States · $15.0M raised
- Headquarters
- Cambridge, Massachusetts
- Website
- solareabio.com
- Total Funding
- $15.0M
- Last Round
- $15.0M Series BMay 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Clinical-stage biotech translating plant-microbiome science into microbial therapeutics for age-related inflammatory conditions such as joint health.
Summary
Solarea Bio is a Biotech company based in Cambridge, United States. It has raised $15.0M in total across 1 round, most recently a $15.0M Series B round in May 2023. Investors include S2G Ventures, Bold Capital Partners and Viking Global.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/solarea-bio"><img src="https://indexed.vc/api/badge/company/solarea-bio" alt="Solarea Bio on Indexed.vc" width="260" height="76" /></a>